References
- North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 Position Statement of the North American Menopause Society. Menopause 2010;17: 242–55
- Whitehead MI, McQueen J, Minardi J, Campbell S. Clinical considerations in the management of the menopause: the endometrium. Postgrad Med J 1978;54:69–73
- Oelkers W. Drospirenone, a progestogen with antimineralocorti-coid properties: a short review. Mol Cell Endocrinol 2004;217: 255–61
- Seeger H, Wallwiener D, Mueck AO. Effects of drospirenone on cardiovascular markers in human aortic endothelial cells. Climacteric 2009;12:80–7
- Schurmann R, Holler T, Benda N. Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens. Climacteric 2004;7:189–96
- Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann NY Acad Sci 1995;761:311–35
- Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996;54:243–51
- Krattenmacher R. Drospirenone: pharmacology and pharmaco-kinetics of a unique progestogen. Contraception 2000;62:29–38
- Archer DF, Thorneycroft IH, Foegh M, . Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause 2005;12:716–27
- Wagaarachchi PT, Sirisena J. Efficiency of Pipelle device in sampling endometrium. Acta Obstet Gynecal Scand 2000;79:793
- Affinito P, Palomba S, Sammartino A, Bonifacio M, Nappi C. Ultrasonographic endometrial monitoring during continuous-sequential hormonal replacement therapy regimen in postmeno-pausal women. Maturitas 2001;39:239–44
- Mutter GL, Ferenczy A. Anatomy and histology of the uterine corpus. In Kurman RJ. Blaustein's Pathology of the Female Genital Tract, 5th edn. New York: Springer-Verlag, 2002:383–419
- Campaner AB, Longo Galvño MA. Application of an easy and useful morphometric technique for immunohistochemistry counting. Gynecol Oncol 2009;112:282–3
- Anderson GL, Judd HL, Kaunitz AM, . Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003;290:1739–48
- Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Smith-Bindman R, Kerlikowske K, Feldstein V, . Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510–17
- Doren M, Rubig A, Coelingh BHJ, Holzgreve W. Impact on uterine bleeding and endometrium thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause 1999;6:299–306
- Sitruk-Ware R. New progestogens: a review of their effects in perimenopausal and postmenopausal women. Drugs Aging 2004; 21:865–83
- Ashkenazi A. Targeting death and decopy receptors of the tumor-necrosis factor superfamily. Nat Rev Cancer 2002;2:420–30
- Borner C. The Bcl-2 family: sensors and checkpoints for life or death decisions. Mol Immunol 2003;39:615–47
- Greene GL, Gilna P, Walterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptors cDNA. Science 1986;231:1150–4
- Dahmoun M, Odmark IS, Risberg B, Karlsson MG, Pavlenko T, Backstron T. Apoptosis, proliferation and sex steroid receptors in postmenopausal endometrium before and during HRT. Maturitas 2004;49:114–23
- Clarke C, Sutherland R. Progestin regulation of cellular proliferation. Endocrinol Rev 1990;11:268–72
- Klaassens AH, van Wijk FH, Hanifi-Moghaddam P, . Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen. Fertil Steril 2006;86:352–61
- Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996;81:4144–7
- Mote PA, Balleine E, McGowan M, Clarke CL. Colonization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1999;84:2963–7
- Mosselman S, Polman J, Dijkema R. ER-b identification and characterization of a novel human estrogen receptor. FEBS J 1996; 392:49–53